4//SEC Filing
Miller Michael 4
Accession 0001209191-12-017976
CIK 0001333170other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:16 PM ET
Size
14.0 KB
Accession
0001209191-12-017976
Insider Transaction Report
Form 4
Miller Michael
President, International
Transactions
- Tax Payment
Common Stock
2012-03-09$18.48/sh−2,286$42,245→ 7,201 total - Award
Common Stock
2012-03-09+3,920→ 6,431 total - Exercise/Conversion
Common Stock
2012-03-09+3,056→ 9,487 total - Award
Restricted Stock Unit
2012-03-09+9,168→ 9,168 total→ Common Stock (9,168 underlying) - Exercise/Conversion
Restricted Stock Unit
2012-03-09−3,056→ 6,112 total→ Common Stock (3,056 underlying)
Footnotes (5)
- [F1]In March 2011, the Compensation Committee of the Board of Directors (the "Compensation Committee") established the NxStage Medical, Inc. (the "Company") 2011 Corporate Bonus Plan with the amount of awards to be determined based upon the satisfaction of 2011 revenue, cash generation and net income targets. On March 9, 2012, the Compensation Committee awarded the reporting person 3,920 shares of common stock based on its evaluation of the achievement of performance criteria established under the 2011 Corporate Bonus Plan.
- [F2]Shares of common stock acquired upon the vesting of restricted stock units.
- [F3]This transaction reflects the withholding of shares of the Company's common stock to satisfy the reporting person's tax liability incurred in connection with the common stock granted to the reporting person on March 9, 2012 pursuant to the Company's 2011 Corporate Bonus Plan and the vesting of the first tranche of restricted stock units (the "Award") on March 9, 2012 pursuant to the Company's 2011 Performance Share Plan.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock
- [F5]In March 2011, the Compensation Committee established the Company's 2011 Performance Share Plan with the amount of awards to be determined based upon the satisfaction of 2011 revenue, cash generation and net income targets. On March 9, 2012, the Compensation Committee granted the reporting person 9,168 restricted stock units, the Award, based on its evaluation of the achievement of performance criteria under the Company's 2011 Performance Share Plan. The Award vested 33 1/3rd% on the March 9, 2012, with the balance vesting in two equal installments on March 9, 2013 and March 9, 2014.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001519023
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:16 PM ET
- Size
- 14.0 KB